CVRx, Inc.

About CVRx, Inc.

CVRx is a medical device company that develops and commercializes Barostim, an implantable neuromodulation therapy using carotid baroreceptor activation to treat patients with heart failure and resistant hypertension. The system delivers electrical pulses to baroreceptors, modulating autonomic nervous system signals to improve cardiovascular function. FDA-approved for heart failure with reduced ejection fraction and resistant hypertension, Barostim aims to reduce hospitalizations and improve quality of life. CVRx conducts clinical trials, manufactures devices, provides physician training, and markets its proprietary technology globally while advancing neurostimulation research for cardiovascular diseases.